ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
US Tech 100
19,430.40
0.14%
Dow Jones
38,834.86
0.15%
Brent Oil
84.645
-0.17%
Bitcoin
65,475.90
0.52%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Genetic Technologies Ltd (GENE)

  7. Genetic Technologies Ltd (GENE) News

GENE

Genetic Technologies (GENE)

Genetic Technologies Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GENE
DateTimeSourceHeadlineSymbolCompany
06/18/20248:00AMGlobeNewswire Inc.Genetic Technologies Expands Operational Capacity in North AmericaNASDAQ:GENEGenetic Technologies Ltd
06/05/20248:00AMGlobeNewswire Inc.GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk TestNASDAQ:GENEGenetic Technologies Ltd
06/05/20246:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
05/29/20248:00AMGlobeNewswire Inc.GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian CancerNASDAQ:GENEGenetic Technologies Ltd
05/29/20246:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
05/28/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
05/23/20248:00AMGlobeNewswire Inc.GeneType and Humanise Health host “Know Your Risk” EventNASDAQ:GENEGenetic Technologies Ltd
05/06/20248:00AMGlobeNewswire Inc.GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesNASDAQ:GENEGenetic Technologies Ltd
04/22/20243:00PMGlobeNewswire Inc.Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
04/18/202412:17PMGlobeNewswire Inc.Genetic Technologies Announces $2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
04/17/20248:00AMGlobeNewswire Inc.New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesNASDAQ:GENEGenetic Technologies Ltd
04/16/20248:00AMGlobeNewswire Inc.GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on YearNASDAQ:GENEGenetic Technologies Ltd
04/11/20248:00AMGlobeNewswire Inc.GTG to pilot GeneType in Breast Screen centers across the U.S.NASDAQ:GENEGenetic Technologies Ltd
04/08/20248:00AMGlobeNewswire Inc.EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”NASDAQ:GENEGenetic Technologies Ltd
04/02/20248:05AMGlobeNewswire Inc.Genetic Technologies’ Digital Strategy Ignites Significant Traction in US MarketNASDAQ:GENEGenetic Technologies Ltd
03/26/20248:00AMGlobeNewswire Inc.GTG Global Collaborations and Innovation UpdateNASDAQ:GENEGenetic Technologies Ltd
03/25/20248:00AMGlobeNewswire Inc.GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised HealthcareNASDAQ:GENEGenetic Technologies Ltd
02/26/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
02/15/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
02/14/20242:14PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GENEGenetic Technologies Ltd
01/31/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
01/31/20248:00AMGlobeNewswire Inc.Launching our most comprehensive test and expanding into new global marketsNASDAQ:GENEGenetic Technologies Ltd
01/09/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
01/05/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
01/05/20248:00AMGlobeNewswire Inc.Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:GENEGenetic Technologies Ltd
01/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
12/28/20238:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
12/27/20238:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
12/20/20235:00PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:GENEGenetic Technologies Ltd
12/14/20238:00AMGlobeNewswire Inc.GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized WellnessNASDAQ:GENEGenetic Technologies Ltd
 Showing the most relevant articles for your search:NASDAQ:GENE

Your Recent History

USOTC
CBIA
Canopus Biopharma (PK)
USOTC
GGSM
Gold and GemStone Mining (PK)
USOTC
MWWC
Marketing Worldwide (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
BLLB
Bell Buckle (PK)
NASDAQ
NVDA
NVIDIA
USOTC
RDGL
Vivos (QB)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
SPZI
Spooz (PK)
USOTC
BMXI
Brookmount Explorations (PK)
NASDAQ
NB
NioCorp Developments
NASDAQ
AVXL
Anavex Life Sciences
USOTC
FNMA
Fannie Mae (QB)
USOTC
WDLF
Decentral Life (PK)
NASDAQ
AMRN
Amarin
USOTC
SAPX
Seven Arts Entertainment (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved